glp 1 problems GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology New research states weight loss

One in five current or former GLP-1 users reported spending more on workout clothing and activewear

Can primary care identify if lower abdominal pain in women is gynecological

Nature 455, 11981204

Substances Tested for The SOA Annual tests for the following substances: Cocaine Synthetic Marijuana Amphetamines (includes Adderall) Opiates Opioids PCP MDMA (i.e., ecstasy, molly) The PES Annual tests for the following categories of substances: Anabolic/Androgenic Steroids (e.g., testosterone, nandrolone, turinabol) Protein and Peptide Hormones (e.g., hGH, GHRP, BPC 157) Anti-estrogenic Agents (e.g., tamoxifen) Selective Androgen Receptor Modulators (SARMS) (e.g., Ostarine) Diuretics (e.g., chlorothiazide) Stimulants (e.g., amphetamines, Ritalin, ephedrine) Gene Doping (e.g., GW1516) Check prohibited substances list here

In type 2 diabetes management, combining a lower dose of GLP-1 therapy with other glucose-lowering medications (such as metformin or SGLT2 inhibitors) may achieve glycaemic targets whilst reducing side effects